Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002283786 | SCV002572871 | pathogenic | Polycystic kidney disease, adult type | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with PKD1 -related disorder (PMID: 12007219). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Fulgent Genetics, |
RCV002283786 | SCV005641250 | pathogenic | Polycystic kidney disease, adult type | 2024-05-28 | criteria provided, single submitter | clinical testing | |
Genomics And Bioinformatics Analysis Resource, |
RCV002283786 | SCV004024077 | likely pathogenic | Polycystic kidney disease, adult type | no assertion criteria provided | research |